Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Strong Cation Exchange Chromatography – V 2.0

Posted on By


Biosimilars: SOP for Strong Cation Exchange Chromatography – V 2.0


Standard Operating Procedure for Strong Cation Exchange Chromatography in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/160/2025
Supersedes SOP/BS/160/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for performing strong cation exchange (SCX) chromatography for intermediate or polishing purification of biosimilar monoclonal antibodies, enabling removal of host cell proteins, aggregates, and charge variants under GMP guidelines.

2. Scope

This SOP is applicable to the use of SCX resins such as SP Sepharose, Fractogel EMD SO₃⁻, and equivalent materials for purification during downstream processing (DSP) of biosimilar products.

3. Responsibilities

  • Production: Execute column operations, monitor parameters, and maintain documentation.
  • QA: Review operation logs and buffer preparations.
  • Engineering: Maintain chromatography skid and support troubleshooting.

4. Accountability

The Downstream Processing Lead is accountable for process adherence, equipment readiness, and data integrity during SCX operations.

5. Procedure

5.1 Column and Buffer Preparation

  1. Verify that the SCX column (e.g., SP Sepharose) is properly packed or pre-packed and labeled.
  2. Prepare the following buffers:
    • Equilibration Buffer: e.g., 20 mM sodium acetate, pH 5.0
    • Elution Buffer: same as equilibration buffer with 0–500 mM NaCl gradient
    • Cleaning Buffer: 0.5 M NaOH
    • Storage Buffer: 20% ethanol
  3. Filter and document all buffer preparations in Annexure-1.

5.2 Column Equilibration

  1. Install the column on the skid and secure connections.
  2. Equilibrate the column with 5–10 column volumes of equilibration buffer at a flow rate of 100–200 cm/hr.
  3. Monitor UV (280 nm), conductivity, and pressure throughout the process.

5.3 Sample Loading

  1. Ensure sample pH is within 0.2 units of the equilibration buffer and has low conductivity.
  2. Load sample at an optimized flow rate (e.g., 100–150 cm/hr) based on column dimensions.
  3. Record UV peak height and monitor pressure differentials.

5.4 Washing and Elution

  1. Wash with equilibration buffer to remove unbound components.
  2. Elute using a linear or stepwise NaCl gradient over 10 column volumes.
  3. Collect fractions based on UV signal or defined conductivity windows.
  4. Analyze fractions for protein content, pH, and purity.

5.5 Cleaning and Storage

  1. Clean column with 0.5 M NaOH for 3–5 column volumes.
  2. Rinse with WFI until neutral pH is achieved.
  3. Store column in 20% ethanol at 2–8°C if not reused immediately.

5.6 Documentation

  1. Record all chromatography parameters, buffer lots, and sample details in Annexures 1–3.
  2. Attach chromatograms to the BMR and submit for QA review.

6. Abbreviations

  • SCX: Strong Cation Exchange
  • DSP: Downstream Processing
  • NaOH: Sodium Hydroxide
  • WFI: Water for Injection

7. Documents

  1. Buffer Preparation Record – Annexure-1
  2. SCX Chromatography Operation Log – Annexure-2
  3. Cleaning and Storage Log – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – GMP Guidelines for Biologics
  • OEM Chromatography Resin Manuals (e.g., Cytiva, Bio-Rad)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Buffer Preparation Record

Buffer Name pH Conductivity Prepared By Date Filter ID
Elution Buffer 5.0 38 mS/cm Sunita Reddy 04/05/2025 FL-2047

Annexure-2: SCX Chromatography Operation Log

Step Flow Rate UV Pressure Start Time End Time Operator
Sample Load 125 cm/hr 0.68 AU 1.3 bar 12:00 12:40 Ajay Verma

Annexure-3: Cleaning and Storage Log

Date Column ID Cleaning Agent Contact Time Final pH Stored In
04/05/2025 SCX-002 0.5 M NaOH 30 min 7.2 20% ethanol

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated UV and pressure monitoring, added cleaning contact time Process validation alignment
See also  Biosimilars: SOP for pH Monitoring and Adjustment in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: SOP for Dissolution Media Filtering and Degassing – V 2.0
Next Post: Gel Manufacturing: SOP for Visual Inspection of Gel-Filled Tubes – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version